ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,530Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 97

$2.07M Total Retail Price of All Prescriptions

Rank: 1 out of 97

583 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 583 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 583 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 10,041 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$165 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
SIMVASTATIN 631 496 1 2
FUROSEMIDE 504 451 2 3
LISINOPRIL 476 400 3 4
METOPROLOL SUCCINATE 451 385 4 8
LEVOTHYROXINE SODIUM 444 382 5 1
METOPROLOL TARTRATE 321 285 6 7
POTASSIUM CHLORIDE 301 246 7 10
OMEPRAZOLE 299 231 8 5
WARFARIN SODIUM 233 205 9 11
GABAPENTIN 229 175 10 18
AMLODIPINE BESYLATE 227 197 11 6
HYDROCHLOROTHIAZIDE 209 191 12 9
METFORMIN HCL 197 125 13 12
CITALOPRAM HBR 159 147 14 20
ATORVASTATIN CALCIUM 157 132 15 14
LOSARTAN POTASSIUM 153 116 16 13
TRAMADOL HCL 144 96 17 21
TRIAMTERENE-HCTZ 141 129 18 30
PREDNISONE 131 108 19 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 120 99 20 36
DIGOXIN 120 120 20 26
SERTRALINE HCL 110 98 22 16
TRAZODONE HCL 108 77 23 42
CARVEDILOL 106 84 24 25
ALENDRONATE SODIUM 106 85 24 19
MIRTAZAPINE 105 103 26 35
ADVAIR DISKUS 104 82 27 40
HYDROCODONE-ACETAMINOPHEN 102 72 S3 28 17
HYDRALAZINE HCL 99 96 29 84
FLUOXETINE HCL 97 64 30 63
MELOXICAM 95 66 31 87
LANTUS 90 79 32 43
SPIRONOLACTONE 86 48 33 33
ALLOPURINOL 84 70 34 22
PAROXETINE HCL 81 52 35 56
ATENOLOL 75 68 36 15
ZOLPIDEM TARTRATE 72 54 37 32
DONEPEZIL HCL 71 71 38 24
CELEBREX 71 48 38 95
LOSARTAN-HYDROCHLOROTHIAZIDE 68 59 40 49
PROPRANOLOL HCL 68 59 40 83
ISOSORBIDE MONONITRATE ER 66 63 42 27
LOVASTATIN 64 64 43 62
VERAPAMIL ER 63 41 44 90
OXYCODONE HCL 62 36 S2 45 114
PROAIR HFA 61 35 46 76
OXYBUTYNIN CHLORIDE ER 61 46 46 171
LACTULOSE 60 59 48 103
LANTUS SOLOSTAR 59 13 49 41
TAMSULOSIN HCL 56 49 50 31
CLOPIDOGREL 56 51 50 34
VENLAFAXINE HCL ER 55 37 52 96
NIFEDIPINE ER 55 55 52 118
PLAVIX 54 51 54 46
METFORMIN HCL ER 51 51 55 89
NEXIUM 51 31 55 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.